Market Reports /
by Melissa Darmawan -
2 years ago
07 Jul 2022 - Despite the materials sector leading the gains, the sector offset losses in industrials, information technology, property, and communication services, the main coal m…
Market Reports /
by Melissa Darmawan -
2 years ago
07 Jul 2022 - Australian stocks have rebounded, lifted by the material sector. Gains in consumer staples and discretionary stocks have offset losses in information technology, whil…
Company News /
by Michael Luu -
3 years ago
28 Apr 2021 - Australasian pharmaceutical distributor and developer AFT (ASX:AFP) has secured an $US18.8 million licensing and commercialisation contract with London-listed Hikma’s…
Market Reports /
by Melissa Darmawan -
3 years ago
01 Apr 2021 - The local share market finished the first day of the month in positive territory building on yesterday's gains. The S&P/ASX 200 index closed 38 points or 0.6% higher …
Company News /
by Melissa Darmawan -
3 years ago
01 Apr 2021 - Commonwealth Bank (ASX:CBA) has completed the sale of its Australian life insurance business, CommInsure Life to AIA Australia.
Market Reports /
by Rachael Jones -
3 years ago
17 Mar 2021 - After a drop at the open the Australian share market couldn’t pull back up and at the closing bell the S&P/ASX 200 index closed 32 points lower, or 0.5 per cent lower…
Company News /
by Rachael Jones -
3 years ago
17 Mar 2021 - AFT Pharmaceuticals (ASX:AFP) has signed a new commercialisation and development agreement for its orphan drug Pascomer.
Company News /
by Rachael Jones -
4 years ago
11 Jan 2021 - AFT Pharmaceuticals (ASX:AFP) report that independent laboratories have found that its new Crystawash Extend Hand Sanitiser meets the accepted standard for killing Co…
Company News /
by Rachael Jones -
4 years ago
19 Nov 2020 - AFT Pharmaceuticals (ASX:AFP) reports continued growth in revenue and normalised earnings as it benefits from growth across its portfolio of over-the-counter and pres…
Market Reports /
by Rachael Jones -
4 years ago
04 Nov 2020 - The ASX closed 0.1% lower. Nanosonics (ASX:NAN) shares rose today on the back of a positive business update. They work in infection protection solutions. As for the s…
Company News /
by Rachael Jones -
4 years ago
04 Nov 2020 - AFT Pharmaceuticals (ASX:AFP) and medicinal cannabis company SETEK today announce an agreement which will see SETEK provide Good Manufacturing Practice (GMP) quality …
Market Reports /
by Rachael Jones -
4 years ago
04 Jun 2020 - Following a broad rally from US markets overnight, the ASX looks set to open higher this morning. If the GDP continues to fall in the next quarter Australia will ente…
Company News /
by Rachael Jones -
4 years ago
27 Feb 2020 - AFT Pharmaceuticals (ASX:AFP) says its six-year term loan facility from CRG maturing on 31 March 2020 is on track to be refinanced with a three year term loan from a …
Company News /
by Ortenzia Borre -
5 years ago
05 Dec 2019 - AFT Pharmaceuticals (ASX:AFP) has today welcomed Medsafe’s decision saying sales of Maxigesic tablets increased by more than 50% after Australia rescheduled codeine c…
Company News /
by Ortenzia Borre -
5 years ago
18 Nov 2019 - AFT Pharmaceuticals (ASX:AFP) has signed licensing agreements worth more than US$1billion for its Maxigesic pain relief medication.
Company News /
by Rachael Jones -
5 years ago
24 Jul 2019 - AFT Pharmaceuticals (ASX:AFT) has successfully registered the intravenous form of its successful ‘Maxigesic’ pain relief medication with the Therapeutic Goods Adminis…
Market Reports /
by Katrina Bullock -
5 years ago
01 Mar 2019 - The ASX continues its 3 day rally. It opened in the green and has been gaining ground through the day to close 0.4% higher. Afterpay Touch Group (ASX:APT) and Bellamy…
Company News /
by Rachael Jones -
5 years ago
01 Mar 2019 - AFT Pharmaceuticals (ASX:AFP) has successfully completed development of a faster release version of its dual action pain-killer, Maxigesic.
Company News /
by Anna Napoli -
6 years ago
06 Nov 2018 - AFT Pharmaceuticals (ASX:AFP) has started the commercialization program for its patented Maxigesic intravenous formulation (IV).
Company News /
by Anna Napoli -
6 years ago
06 Mar 2018 - AFT Pharmaceuticals (ASX:AFP) has announced its codeine-free painkiller Maxigesic is now the largest selling paracetamol-ibprofen combination painkiller in Australian…
Market Reports /
by Jessica Ellerm -
7 years ago
27 Dec 2017 - Market Outlook in 3 mins: Aus shares set to open higher on surge in oil price. Wall St lower, Apple stocks down 2.5%. AFT Pharmaceuticals (ASX:AFP) announces its pain…
Market Reports /
by Kathy Skantzos -
7 years ago
23 Nov 2017 - Market Outlook in 3 mins: In the last day of trade before the Thanksgiving holiday in the US tomorrow, the US markets took a turn from yesterday’s gains, but despite …
Company News /
by Kathy Skantzos -
7 years ago
12 Oct 2017 - AFT Pharmaceuticals (ASX:AFP) announces results of its clinical trial for its intravenous Maxigesic painkiller. The study shows the intravenous paracetamol and ibupro…
Market Reports /
by Jessica Amir -
7 years ago
29 Sep 2017 - Market at Midday: Oil price dip caps gains, leading to a flat start. Materials muster up. RBA reports flat private credit data month-on-month. AFT Pharmaceuticals (AS…
Market Reports /
by David Chau -
8 years ago
28 Dec 2016 - Nasdaq posts new record high: ASX to open flat. AFT Pharmaceuticals (ASX:AFP) enters alliance agreement with Italian pharmaceutical company Angelini.